The popularity of Viagra initially fueled a boom for pharma, nevertheless recent developments present a uncertain outlook for shareholders. Off-patent alternatives are eroding revenue, and persistent legal battles add https://laylazerr489620.bloggerbags.com/46894072/the-blue-pill-and-big-pharma-a-risky-play